| Affiliation: | 1. National Genetics Reference Laboratory (Wessex), Salisbury, UK;2. Human Genetics Division, School of Medicine, University of Southampton, UK;1. Medical Oncology Training Program, University of Toronto, Canada;2. Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada;1. The University of Texas MD Anderson Cancer Center, Houston, TX, USA;2. University of Campinas, Distrito de Barao Geraldo, Campinas, Brazil;3. Hospital de Especialidades CMN La Raza, Instituto Mexicano del Seguro Social, Seris y Zaachila s/n, Colonia La Raza, Mexico, DF, Mexico;4. Banco Municipal de Sangre, Dpt. Clinicas Hematologicas, Hemato-Oncologia, Esq Pirineos, Caracas, DC, Venezuela;5. Hospital Britanico, Buenos Aires, Argentina;6. The Gujarat Cancer and Research Institute, Ahmedabad, India;7. Peking University People''s Hospital, Peking University Institute of Hematology, Beijing, China;8. Kidwai Memorial Institute of Oncology, Bangalore, India;9. HCG Curie Centre of Oncology, Bangalore, India;10. Russian Research Institute of Hematology and Transfusiology, St Petersburg, Russia;11. Universidade Federal de São Paulo, Hospital Santa Marcelina, São Paulo, Brazil;12. Shanghai Ruijin Hospital, Shanghai, China;13. Department of Haematology, Jagiellonian University Medical College, Kraków, Poland;14. University of São Paulo Medical School, São Paulo, Brazil;15. Guangzhou KingMed Center for Clinical Laboratory Co, Ltd, Guangzhou, Guangdong, China;p. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;q. Novartis Healthcare Pvt Ltd, Raheja Mind Space, Hitech City Madhapur/Hyderabad, Rangareddy, India;r. Novartis Pharma SAS, Oncology Global Development & Global Medical Affairs, France;s. Charité - University of Medicine Berlin, Campus Virchow-Klinikum, Medizinische Klinik mS, Hämatologie und Onkologie, Berlin, Germany;1. Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia;;2. School of Medicine, and;3. School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia;;4. School of Pharmacy and Medical Science, University of South Adelaide, Adelaide, Australia;;5. Department of Haematology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia;;6. Australasian Leukaemia and Lymphoma Group, East Melbourne, Australia;;7. Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Australia;;8. University of Melbourne, Parkville, Australia;;9. Department of Haematology, Austin Hospital, Melbourne, Australia;;10. Department of Haematology, Flinders University and Medical Centre, Bedford Park, Australia; and;11. Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia;1. Division of Hematology/Medical Oncology, Knight Cancer Insitute, Oregon Health & Science University, Portland, OR, USA;1. Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, GME office, 12902 USF Magnolia Drive, Tampa, FL 33612, USA;2. University of South Florida, Morsani College of Medicine, 12901 Bruce B. Downs Blvd., Tampa, FL 33612, USA |
